IF=17.7 | TBS mode: Exploring the unknown, promising prospects
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Repetitive transcranial magnetic stimulation (rTMS) was approved by the U.S. Food and Drug Administration (FDA) in 2008 for the treatment of major depression that is refractory to multiple medications. The initial treatment time of rTMS protocol is about 45 minutes, once a day for 20-30 days. This treatment... Read more